Stocks Consumer discretionary RMTG
OTC · Consumer discretionaryRegenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. brought in $9.4M of revenue over the twelve months to June 30, 2026, up 94.3% from a year earlier. It posted a net loss of $9.4M. In fiscal 2025 capital spending exceeded operating cash flow by $1.3M. At June 30, 2026 it held $1.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.
Watch RMTG in 60 secondsWhat Regenerative Medical Technology Group Inc. does
Regenerative Medical Technology Group Inc. is registered with the SEC under industry code SIC 5990 (Retail-Retail Stores, NEC). Its shares trade on OTC under the ticker RMTG.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $5.1M | -$7.8M | -$0.62 | -$1.3M |
| 2024 | $4.1M | -$5.6M | -$0.44 | $635.3K |
| 2023 | $2.4M | -$9.8M | -$0.79 | -$804.8K |
| 2022 | $1.5M | -$5.5M | -$0.45 | -$1.3M |
| 2021 | $437.9K | -$12.9M | -$1.12 | n/a |
| 2020 | $55.1K | -$5.9M | -$0.63 | -$422.7K |
Full financial statements: income, balance sheet and cash flow
Where RMTG ranks in Consumer discretionary
Latest SEC filings
What Regenerative Medical Technology Group Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 28, 2026Form DEF 14C filing DEF 14C
- August 25, 2026Other event 8-K
- August 19, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 309% to $4M versus the same quarter last year; diluted EPS -$0.22 versus -$0.12.
- August 18, 2026Form PRE 14C filing PRE 14C
- August 14, 2026Late quarterly report notice NT 10-Q
- June 9, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 93% to $2.6M versus the same quarter last year; diluted EPS -$0.07 versus -$0.06.
- May 15, 2026Late quarterly report notice NT 10-Q
- May 14, 2026Annual report 10-K · period to December 31, 2025Revenue rose 24% to $5.1M versus the prior year; diluted EPS -$0.62 versus -$0.44.
- April 1, 2026Late annual report notice NT 10-K
- November 19, 2025Quarterly report 10-Q · period to September 30, 2025Revenue rose 20% to $1.2M versus the same quarter last year; diluted EPS -$0.35 versus -$0.07.
Questions about RMTG
What does Regenerative Medical Technology Group Inc. do?
Regenerative Medical Technology Group Inc. is registered with the SEC under industry code SIC 5990 (Retail-Retail Stores, NEC). Its shares trade on OTC under the ticker RMTG.
Is Regenerative Medical Technology Group Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $9.4M on revenue of $9.4M.
How much revenue does Regenerative Medical Technology Group Inc. make?
Over the twelve months to June 30, 2026 Regenerative Medical Technology Group Inc. reported revenue of $9.4M. That is 94.3% more than a year earlier.
When did Regenerative Medical Technology Group Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the form DEF 14C filing from August 28, 2026.
Similar companies
Compare RMTG with
Follow RMTG
Get an email when Regenerative Medical Technology Group Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow RMTG: get an email when it filesWhere the numbers come from
Financial figures are the values Regenerative Medical Technology Group Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.